LKB1/STK11 is a tumor suppressor in the progression of myeloproliferative neoplasms Journal Article


Authors: Marinaccio, C.; Suraneni, P.; Celik, H.; Volk, A.; Wen, Q. J.; Ling, T.; Bulic, M.; Lasho, T.; Koche, R. P.; Famulare, C. A.; Farnoud, N.; Stein, B.; Schieber, M.; Gurbuxani, S.; Root, D. E.; Younger, S. T.; Hoffman, R.; Gangat, N.; Ntziachristos, P.; Chandel, N. S.; Levine, R. L.; Rampal, R. K.; Challen, G. A.; Tefferi, A.; Crispino, J. D.
Article Title: LKB1/STK11 is a tumor suppressor in the progression of myeloproliferative neoplasms
Abstract: The myeloproliferative neoplasms (MPN) frequently progress to blast phase dis-ease, an aggressive form of acute myeloid leukemia. To identify genes that suppress disease progression, we performed a focused CRISPR/Cas9 screen and discovered that depletion of LKB1/Stk11 led to enhanced in vitro self-renewal of murine MPN cells. Deletion of Stk11 in a mouse MPN model caused rapid lethality with enhanced fibrosis, osteosclerosis, and an accumulation of imma-ture cells in the bone marrow, as well as enhanced engraftment of primary human MPN cells in vivo. LKB1 loss was associated with increased mitochondrial reactive oxygen species and stabilization of HIF1α, and downregulation of LKB1 and increased levels of HIF1α were observed in human blast phase MPN specimens. Of note, we observed strong concordance of pathways that were enriched in murine MPN cells with LKB1 loss with those enriched in blast phase MPN patient specimens, supporting the conclusion that STK11 is a tumor suppressor in the MPNs. Significance: Progression of the myeloproliferative neoplasms to acute myeloid leukemia occurs in a substantial number of cases, but the genetic basis has been unclear. We discovered that loss of LKB1/STK11 leads to stabilization of HIF1a and promotes disease progression. This observation provides a potential therapeutic avenue for targeting progression. ©2021 American Association for Cancer Research.
Journal Title: Cancer Discovery
Volume: 11
Issue: 6
ISSN: 2159-8274
Publisher: American Association for Cancer Research  
Date Published: 2021-06-01
Start Page: 1398
End Page: 1410
Language: English
DOI: 10.1158/2159-8290.Cd-20-1353
PUBMED: 33579786
PROVIDER: scopus
PMCID: PMC8178182
DOI/URL:
Notes: Article -- Export Date: 1 July 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Raajit Kumar Rampal
    338 Rampal
  2. Ross Levine
    775 Levine
  3. Richard Patrick Koche
    173 Koche